Perinatal results of hemodynamic and conservative temporizing treatment in severe pre-eclampsia

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 53, Issue 3, 1994, Pages 175-181

  Visser, Willy ^a   van Pampus, Maria G ^b   Treffers, Pieter E ^b   Wallenburg, Henk C S ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Invasive hemodynamic monitoring; Perinatal mortality in pre eclampsia; Plasma volume expansion; Pre eclampsia; Temporizing treatment

Indexed keywords

DIAZEPAM; DIHYDRALAZINE; FENOTEROL; MAGNESIUM SULFATE; METHYLDOPA; PHENOBARBITAL;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS; FETUS OUTCOME; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PERINATAL MORTALITY; PLASMA VOLUME; PREECLAMPSIA; PRIORITY JOURNAL; VASODILATATION;

EID: 0028350391     PISSN: 00282243     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-2243(94)90116-3     Document Type: Article

References (30)

1. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy
2. Central hemodynamic observations in untreated preeclamptic patients
3. Plasma volume expansion in the treatment of preeclampsia
4. Antihypertensive effect of plasma volume expansion in pregnancy-associated hypertension
5. Hemodynamics in hypertensive pregnancy
6. Haemodynamic changes in gestational proteinuric hypertension: the effects of rapid volume expansion and vasodilator therapy
7. Hemodynamic measurements with Swan-Ganz catheter in women with severe proteinuric gestational hypertension (pre-eclampsia)
8. Conservative management of preeclamptic and eclamptic patients: a re-evaluation
9. Severe preeclampsia-maternal and fetal outcome
10. Outcome of pregnancies complicated by severe hypertension and delivered before 34 weeks; stepwise logistic regression analysis of prognostic factors
11. Proteinuria and outcome of 444 pregnancies complicated by hypertension
12. Pregnancy outcome in 303 cases with severe pre-eclampsia
13. Management and outcome of pregnancy complicated by severe preeclampsia of early onset
14. Agressive or expectant management for patients with severe preeclampsia between 28–34 weeks' gestation: a randomized controlled trial
15. A protocol for managing severe preeclampsia in the second trimester
16. The management of severe toxemia in patients at less than 36 weeks' gestation
17. Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester
18. Fetal and neonatal outcome in patients with severe pre-eclampsia before 34 weeks
19. Nifedipine in the treatment of severe preeclampsia
20. Effect of colloid volume expansion on glomerular barrier sizeselectivity in humans
21. Preeclampsia associated with hemolysis, elevated liver enzymes, and low platelets — an obstetric emergency?
22. Antepartum reversal of hematologic abnormalities associated with the HELLP-syndrome. A report of three cases
23. Prolongation of premature gestation in women with hemolysis, elevated liver enzymes and low platelets
24. Case-control study of severe preeclampsia of early onset
25. Complications of beta-sympathomimetic tocolytic agents
26. Side effects of labetalol in newborn infants
27. Severe adverse effects of maternal labetalol in a premature infant
28. Simultaneous investigations of maternal cardiac output and fetal blood flow during hypervolemic hemodilution in preeclampsia — preliminary observations
29. Reappearance of end-diastolic velocities in the umbilical artery following maternal volume expansion: a preliminary study
30. Invasive hemodynamic monitoring in pregnancy